NEWLY DIAGNOSED CANCER IN A COHORT OF CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB:A 3 YEARS LONGER FOLLOW UP FROM A MULTICENTER MATCHED-PAIR STUDY.